Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-blind, Single-treatment Study to Evaluate the Effects of Vildagliptin on Response to an Intravenous Glucose Load in Pre-diabetic Subjects With Impaired Fasting Glucose

NCT00312130 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00312130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00312130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-blind, Single-treatment Study to Evaluate the Effects of Vildagliptin on Response to an Intravenous Glucose Load in Pre-diabetic Subjects With Impaired Fasting Glucose
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2005
Completion date
November 30, 2006
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pre-diabetes